SOLICITATION NOTICE
65 -- Molecular Diagnostics Analyzers and Reagents
- Notice Date
- 6/11/2024 12:17:59 PM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- W40M MRCO PACIFIC FORT SHAFTER HI 96858-5098 USA
- ZIP Code
- 96858-5098
- Solicitation Number
- W81K0224Q0043
- Response Due
- 7/12/2024 1:00:00 PM
- Archive Date
- 07/27/2024
- Point of Contact
- Leslie Takayama
- E-Mail Address
-
leslie.m.takayama.civ@health.mil
(leslie.m.takayama.civ@health.mil)
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice.� This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. Medical Readiness Contracting Office � Pacific intends to solicit, negotiate, if necessary, and award a Firm Fixed Price Contract for a cost per test for molecular diagnostics analyzers and reagents capable of running multiplex testing for qualitative detection and genotyping of the DNA of Human Papilloma Virus (HPV) at Madigan Army Medical Center (MAMC), Washington. This is a request for quotation (RFQ).� This solicitation number is W81K0224Q0043.� The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2024-01.� The Standard Industrial Classification Code is 6515, size standard is 1,250 employees and the NAICS is 325413.� This is NOT a Small Business Set-Aside.� �Provision at 52.212-1, Instructions to Offerors � Commercial, and its addendum applies to this acquisition and a statement regarding any addenda to the provision. See W81K0224Q0043Att1 Provision at 52.212-2 � Commercial Items and its addendum applies to this acquisition. See W81K0224Q0043Att1. Offerors shall include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications � Commercial Items, with its offer. The clause at 52.212-4 Contract Terms and Conditions --� Commercial Items, and its addendum applies to this acquisition.� See W81K0224Q0043Att1. The deviation to clause at 52.212-5, Contract Terms and Conditions Required to Implement Statues of Executive Orders � Commercial Items, applies to this acquisition. �See W81K0224Q0043 for the FAR clauses that are applicable to this. The Defense Priorities and Allocation System (DPAS) and assigned rating is not applicable. The Government intends to award a firm fixed-price type contract for a base period of 01 Oct 2024 through 30 September 2025 with four (4) one-year options to the successful quoter.�� Contract Requirements � The successful quoter shall be required to provide the cost per test for molecular diagnostic analyzer and reagents capable of running multiplex testing for qualitative detection and genotyping of HPV, with the minimum requirements given in the attachment W81K0224Q0043Att1.� Contractors shall quote their unit pricing based on the estimated quantities identified in each Contract Line Item Number. Point of contact for this solicitation is Leslie Takayama, email: leslie.m.takayama.civ@health.mil Responses must be received by: 12 July 2024 @ 10:00 AM HST. **SEE ATTACHMENT W81K0224Q0043Att1 FOR DELIVERY AND ACCEPTANCE, CONTRACT LINE ITEMS, AND TERMS AND CONDITIONS***
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/9cd89cf934af460298717a11bf803ee2/view)
- Place of Performance
- Address: Joint Base Lewis McChord, WA, USA
- Country: USA
- Country: USA
- Record
- SN07093683-F 20240613/240611230130 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |